Abstract: Cleaning tools for cleaning the pull cable of an ingot puller apparatus and methods for cleaning the pull cable are disclosed. The cleaning tool includes a chamber for receiving the pull cable. Pressurized fluid is discharged through one or more nozzles to detach debris from the pull cable. The fluid and debris are collected in an exhaust plenum of the cleaning tool and are expelled through an exhaust tube. The cleaning tool includes one or more guides that guide the cleaning tool in an upper segment of the ingot puller apparatus.

Abstract: The present invention discloses a pressing pump and a liquid container. The pressing pump comprises a pump body, a one-way valve, a valve stem assembly, a pressing head and an annular part. The pump body is provided with an accommodating cavity. The annular part is inserted into the accommodating cavity, and the outer circumference of the annular part sealably abuts against an inner wall of the accommodating cavity. The pressing head is provided with a second channel which communicates with the first channel. The second channel has a first opening which is disposed on the side wall of the pressing head close to the pump body and is located at an outer side of the annular part. The pressing pump provided in the present invention can reduce the circumstances in which external moisture enters the interior of the pump body, and improve the waterproof performance.

Abstract: A method for manufacturing an electronic device is provided. The method includes providing a first substrate. The method further includes forming a bank layer on the first substrate. The bank layer includes a bank wall and a first opening, and the first opening adjacent to the bank wall. The method further includes forming a light conversion layer in the first opening. The method further includes forming a spacer on the bank wall. The method further includes providing a second substrate. The method further includes transferring a plurality of electronic units to the second substrate. The method further includes overlapping the first substrate and second substrate, so that the spacer is located between the first substrate and the second substrate.

Abstract: The present disclosure relates to the field of display technology and provides a pixel array, a display panel and a metal mask. The pixel array includes a plurality of pixel units, and each pixel unit is composed of two red sub-pixels, two blue sub-pixels and a green sub-pixel. In each pixel unit, connection lines of centers of the red sub-pixels and the blue sub-pixels in a same row and a same column form a parallelogram, the two red sub-pixels and the two blue sub-pixels are located at diagonal positions of the parallelogram respectively, and a center of the green sub-pixel is located at an intersection position of diagonal lines of the parallelogram. Along the row direction, two adjacent parallelograms are in a translational relationship and share a column side. Along the column direction, two adjacent parallelograms are in a mirror-image relationship and share a row side.

Abstract: Provided is a method for resource selection. The method is applicable to a terminal device, and includes selecting a transmission resource from a first resource set after resource exclusion on the first resource set; wherein any resource within the first resource set is a first resource, wherein the first resource corresponds to N consecutive time units in a time domain, N being an integer greater than 1.

Abstract: A display panel includes: a main display area, a peripheral wiring area, a substrate, an array layer, a pixel definition layer and light-emitting devices. The array layer includes pixel driving circuits located in the main display area. The pixel definition layer includes openings that include first openings and second openings. The first openings are located in the main display area, and the second openings are located in the peripheral wiring area. The light-emitting devices include first light-emitting devices and second light-emitting devices. The first light-emitting devices are in one-to-one correspondence with the first openings, and the second light-emitting devices are in one-to-one correspondence with the second openings. The light-emitting device includes an anode.

Abstract: Semiconductor structures and methods are provided. An exemplary semiconductor structure according to the present disclosure includes a two-port static random access memory (SRAM) cell having a write port portion and a read port portion electrically coupled to the write port portion. The read port portion includes a transistor having a first source/drain feature and a second source/drain feature. The semiconductor structure also includes a first plurality of metal lines comprising a write bit line and a complementary write bit line, wherein the first plurality of metal lines are positioned at a first metal interconnect layer, wherein the first metal interconnect layer is disposed over the first source/drain feature. The semiconductor structure also includes a read bit line positioned at a second metal interconnect layer, where the second metal interconnect layer is disposed under the first source/drain feature.

Abstract: A flexible display panel and a flexible array substrate are provided. The flexible display panel includes a flexible base and a thin film transistor. The thin film transistor includes an active layer, and the active layer includes an active layer, a gate electrode insulation layer, and a gate sequentially stacked in a direction away from the flexible base. The active layer includes a channel region, and the gate electrode insulation layer covers the channel region. A plurality of open pores are defined in the active layer, and the open pores penetrate through at least one part of the active layer. At least a part of the open pores are located in the channel region, and the gate electrode insulation layer fills the at least a part of the open pores.

Abstract: A panel transfer device according to one or more embodiment may include a base; an arm rotatably connected to the base, which includes a first detector; an end effector connected to the arm, including: a connector rotatably connected to the arm; a wrist connected to the connector, including a second detector; and a pair of forks connected to the wrist, including sensor. In response to the end effector gripping the panel, the sensor detects displacement of the panel in a first direction, the end effector rotates to a position where the first and second detectors face each other, the first and second detectors communicate to detect displacement of the panel in a second direction, and the panel transfer device calculates a correction amount based on the detected displacement of the panel in the first direction and in the second direction, and places the panel based on the correction amount.

Abstract: Provided are compounds of Formula (I) or pharmaceutically acceptable salts thereof, wherein the variables in Formula (I) are as defined herein; and methods for their use and production.

Abstract: An eye detection physiological information capture device includes a first light plate assembly, and a second light plate assembly arranged in a housing. The first light plate assembly includes a first light source module, and a signal detection module. The signal detection module detects the reflection of light emitted from the first light source module towards an eye. The second light plate assembly includes a second light source module, a lens assembly, a first camera module, and a second camera module. The lens assembly is arranged to enable light rays from the second light source module to respectively irradiate the eye. The first camera module can capture a three-dimensional image of the eye and the second camera module can capture a fundus image of the eye by detecting the reflection of light emitted from the second light source module towards the eye.

Abstract: Disclosed herein is an internally fixed lipid vesicle generated from a cell that substantially preserves the membrane characteristics of the cell and methods of using the internally fixed lipid vesicle.

Abstract: The present invention provides a method of treatment and composition for CDC7 inhibitor combinational therapy for treatment of proliferative diseases. In an embodiment, the composition of the present invention comprises a therapeutically effective amount of a combination of a CDC7 inhibitor of the present invention or a pharmaceutically acceptable salt thereof and one or more antineoplastic agents. In an embodiment, the CFC7 inhibitor comprises granaticin B. In an embodiment, the antneoplastic agent comprises azacitidine and venetoclax. The present invention further provides a method of treatment comprising the step of administration to a subject suffering from proliferative disease of any embodiment of the composition of the present invention.

Abstract: A glove and method of forming the same is disclosed. The glove includes a wrist region, a palm region, and a plurality of digit regions each having a tip provided at one end of a fingertip region thereof. The tip is remote from the palm region. A texture is provided on at least one tip of the plurality of digit regions. The texture is provided on an exterior of an arcuate surface of the at least one tip, where the arcuate surface is generally orthogonal to a longitudinal axis of the digit region having the textured tip. In other embodiments, a texture is also provided on a circumferential surface of the fingertip region of another of the plurality of digit regions. The texture forms a pattern on the tip or the fingertip region. In one instance, the pattern is a sand pattern produced by micro-etching the glove material.

Abstract: A microneedle patch for enhancing accumulation of PpIX in a solid tumor and a preparation method therefor. The method includes steps of: dissolving albumin into Dubos medium, taking the albumin as a template, adding CuCl2 and CaCl2 for mineralization to obtain CCP nanoparticles; loading CAT and 5-ALA onto a surface of the CCP nanoparticles by a one-step carbodiimide coupling method and an electrostatic-adsorption method, respectively, to obtain CCPCA nanoparticles; loading the CCPCA nanoparticles and microneedle-matrix solution into a microneedle mold, after vacuum drying and demolding, obtaining the microneedle patch for enhancing accumulation of PpIX in a solid tumor.

Abstract: That published in this invention belongs to the technical field of blower, it is concretely a kind of double duct hairdryer, including the shell components, which is internally mounted with the driving component, conduction heating component and exhaust component, the internal components can be installed and be set as straight shape, the driving component is mounted at the internal right end of the shell component, and by the plasma technique with double emitter, it can release positive ion and negative ion at the same time, and it can quickly neutralize positive charges and negative charges after acting on hair, so that hair is soft and bright, being designed as the air duct with double outlets in a straight line and by means of airstream rectification, this invention reduces the loss of wind rate in the air duct, so as to increase the wind speed and wind rate, by the design of air duct with double outlet, hollow slot can be utilized to let air be held between the two outlets, so that the contact area of hai

Abstract: Provided is an E. coli expressed recombinant human microplasmin (E-?Plm), a production method thereof, a pharmaceutical composition and a kit comprising thereof, an application of the pharmaceutical composition and the kit in treating thromboembolism related diseases and a method of treating thromboembolism related diseases by using the pharmaceutical composition and the kit. The zymogen version of the E-?Plm or E-?Plg is unstable and can undergo autoactivation. Moreover, the in vivo half-life of the E-?Plm is significantly shorter than yeast expressed microplasmin (Y-?Plm), which allows the E-?Plm, the pharmaceutical composition and the kit effective in treating thromboembolism diseases but with reduced bleeding side effects.

Abstract: A cooler table includes a blow-molded tabletop that forms a tray for holding ice, and two collapsible leg assemblies for supporting the tabletop. The tabletop has an upper surface, a perimeter lip, and a lower surface. The upper surface slopes downward from its outer edges to accommodate flow of liquid toward an upper drain aperture as the ice melts. The lower surface of the tabletop includes an outer perimeter portion, a central portion, a first end portion, a second end portion, a first side portion, and a second side portion. The outer perimeter portion includes a first side perimeter portion, a second side perimeter portion, a first end perimeter portion, and a second end perimeter portion. The central portion is disposed between the first and second side perimeter portions and between the first and second end perimeter portions. The central portion is spaced apart from the upper surface and has a lower drain aperture that is aligned with the upper drain aperture.

Abstract: A collapsible wagon can include a base frame; a pair of front wheels coupled to the base frame; a pair of rear wheels coupled to the base frame via a suspension system; a handle coupled to the base frame; a lever hingedly connected to the base frame adjacent to a first end of the wagon; a holder frame hingedly connected to the lever adjacent to a second end of the wagon; a seat back hingedly connected to the lever such that when the seat back is opened, the seat back and the lever rotate into a locked relationship; a release mechanism positioned to enable a user to release the seat back from the locked relationship with the lever; and wherein the lever includes a lever foot pedal positioned and arranged for a user to step on the lever foot pedal to hingedly open the lever relative to the base frame.

Abstract: This application relates to modified influenza B hemagglutinin polypeptides and nucleic acids, such as messenger ribonucleic acids (mRNAs), encoding the same, as well as compositions comprising the same, vaccines comprising the same, and methods of using the same, such as in the prevention and/or treatment of diseases or conditions caused by influenza B viruses.